171 related articles for article (PubMed ID: 17695809)
1. [New findings with RAS inhibitors in diabetic nephropathy].
Ito S
Nihon Jinzo Gakkai Shi; 2007; 49(5):485-90. PubMed ID: 17695809
[No Abstract] [Full Text] [Related]
2. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
Fronczyk A; Majkowska L
Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
[TBL] [Abstract][Full Text] [Related]
3. Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks.
Campese VM; Park J
J Hypertens; 2006 Nov; 24(11):2157-9. PubMed ID: 17053534
[No Abstract] [Full Text] [Related]
4. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
Dalla Vestra M; Simioni N; Masiero A
Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
[TBL] [Abstract][Full Text] [Related]
5. [The renin-angiotensin system].
Hilgers KF
Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
[No Abstract] [Full Text] [Related]
6. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
8. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
9. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
Jorde UP
Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
[TBL] [Abstract][Full Text] [Related]
10. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system and its blockade in diabetic nephropathy: main focus on the role of aldosterone.
Schjoedt KJ
Dan Med Bull; 2011 Apr; 58(4):B4265. PubMed ID: 21466768
[TBL] [Abstract][Full Text] [Related]
12. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
13. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
Hirsch S
Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
[No Abstract] [Full Text] [Related]
14. Aliskiren combined with losartan in diabetes and nephropathy.
Lindner T
N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
[No Abstract] [Full Text] [Related]
15. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
16. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
17. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
18. [Present status and the future of diabetic nephropathy].
Haneda M
Nihon Jinzo Gakkai Shi; 2007; 49(5):496-8. PubMed ID: 17695811
[No Abstract] [Full Text] [Related]
19. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.
Jimenez J; Safranek S; Viera AJ
Am Fam Physician; 2007 Aug; 76(3):423-4. PubMed ID: 17708144
[No Abstract] [Full Text] [Related]
20. [Anti-atherosclerotic effect].
Takai S; Miyazaki M
Nihon Rinsho; 2006 Jul; 64 Suppl 5():518-23. PubMed ID: 16895221
[No Abstract] [Full Text] [Related]
[Next] [New Search]
